90TEN strengthens senior management team to enhance behavioural science and creative services

Written by: Nola Cadman
Published on: 28 Aug 2020

25 August 2020, London – 90TEN, part of Envision Pharma Group, today announced the establishment of a new role of Head of Behavioural Sciences along with three promotions within the senior management team and two new hires, enhancing the company’s behavioural science and creative capabilities.

Mark Lakeram, previously 90TEN’s Director of Scientific Services, will be taking on a new role as Group Director, Head of Behavioural Science, to lead 90TEN’s behavioural science function across all divisions of the company. Mark’s remit will be to build a behavioural science centre of excellence delivering insight-driven communications services based on an academic understanding of human behaviour. He will be joined by Jenny Squibbs, Associate Director, who will take on responsibility of leading behavioural science services within the 90TEN Medical team, the medical communications division of 90TEN.


“Now more than ever during these challenging times, it’s important that we understand the nuances of human behaviour so we can become more effective communicators and educators. Behavioural science has always underpinned our work, so we are thrilled to have Mark and Jenny step into their new roles to help us take these services to the next level,” said Alison Doughty, Managing Director of 90TEN’s Medical division.

90TEN’s Creative Services has been bolstered by the promotion of James Duggan to Director, Creative Services, 90TEN Medical. In this role James will drive the implementation of new insight-led creative tools. Amy O’Connor has taken on new responsibilities and will lead creative output across the PR side of the company taking on the title of Associate Director, Creative Services, 90TEN Communications. Both James and Amy will be responsible for driving innovation and creativity across 90TEN’s client work.

90TEN has further strengthened its senior management team with the promotion of Niamh Mangan to Director within 90TEN Medical as well as Ruth McIntyre to Associate Director within the 90TEN Communications division.

Jamie Hall and Jessica Greenman have joined 90TEN as Account Directors. Jamie, who has joined 90TEN Medical, previously worked at ArticulateScience (part of Nucleus Global). Jessica, who has joined 90TEN Communications, has previously worked with M&F Health, Porter Novelli and TogoRun. Sophie Cremin has also been promoted to Senior Account Director within 90TEN Communications. 

90TEN’s growth is expected to continue, with plans to welcome more team members to its medical and communications divisions in 2020.

About 90TEN

90TEN Ltd. is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education, communications and patient advocacy services and is comprised of two divisions:

  • 90TEN Communications – public relations consultancy
  • 90TEN Medical – medical communications and education consultancy



90TEN has worked with behavioural psychologists to develop its own Feel-Think-Do™ evidence-based suite of tools that seek to understand the human emotions, thought processes and environmental factors that sit behind each communication challenge we face. These behavioural science methodologies are used to maximize brand and health outcomes.

90TEN is one of the leading healthcare communications consultancies in Europe having been named EMEA Healthcare Consultancy of the Year at the 2020 SABRE Awards, Best Agency in Europe at the 2019 PR Week Global Awards and Communications Consultancy of the Year at the 2019 and 2020 Communiqué Awards. 90TEN is part of the Envision Pharma Group – a global provider of evidence-based communication services and industry-leading technology solutions. To find out more, visit www.90ten.co.uk.

About Envision

Pharma Group

Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision®) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 14 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), and Wilmslow; one in Serbia – Subotica; one in Hungary – Szeged; four in the United States – Fairfield and Glastonbury, CT, Philadelphia, PA, Warren, NJ; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs around 800 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit www.envisionpharmagroup.com.